Close

Jupiter Wellness Licenses Photocil(TM), a Novel Topical Treatment of Psoriasis, Vitiligo, Pruritis and Atopic Dermatitis

Go back to Jupiter Wellness Licenses Photocil(TM), a Novel Topical Treatment of Psoriasis, Vitiligo, Pruritis and Atopic Dermatitis
(NASDAQ: JUPW) Delayed: 1.52 --0 (-0%)
Previous Close $1.52    52 Week High
Open $1.52    52 Week Low
Day High $1.52    P/E N/A 
Day Low $1.52    EPS
Volume 32,243